Adamis Pharmaceuticals Corp 4
4 · Adamis Pharmaceuticals Corp · Filed Aug 17, 2015
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Purchase
Common Stock
2015-08-13$3.30/sh+5,000$16,494→ 25,000 total - Purchase
Common Stock
2015-08-14$3.40/sh+2,000$6,800→ 27,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted avergae price. These shares were purchased in multiple transactions at prices ranging from $3.24 to $3.30, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.358 to $3.426, inclusive. The reporting person undertakes to provide to Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.